| Symbol | NSRX |
|---|---|
| Name | NASUS PHARMA LTD |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 29 HARAKEVET ST, TEL AVIV - YAFO, L3 6618003 |
| Telephone | 972 54-255-3956 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0002029039 |
| Description | None |
Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
Read moreNew Form SCHEDULE 13G/A - Nasus Pharma Ltd <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003431 <b>Size:</b> 15 KB
Read moreNew Form 3 - Nasus Pharma Ltd <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001493152-26-035646 <b>Size:</b> 3 KB
Read moreNasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. OGrady as Chief Executive Officer to Lead Strategic Growth
Read moreDirector Teleman Dan Benjamin 🟢 acquired 6.5K shares of Nasus Pharma Ltd (NSRX) at $3.10 Transaction Date: Jun 17, 2026 | Filing ID: 029484
Read moreNew Form SCHEDULE 13G - Nasus Pharma Ltd <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001193125-26-225115 <b>Size:</b> 141 KB
Read moreDirector Teleman Dan Benjamin 🟢 acquired 2.9K shares of Nasus Pharma Ltd (NSRX) at $3.76 Transaction Date: Apr 22, 2026 | Filing ID: 018607
Read moreNew Form SCHEDULE 13G - Nasus Pharma Ltd <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0002073679-26-000045 <b>Size:</b> 101 KB
Read more